日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Highlights in oesophagogastric cancers from ESMO congress 2025

ESMO 2025年大会食管胃癌研究亮点

Petrillo, A; Pietrantonio, F; Fleitas-Kanonnikoff, T

Multidisciplinary discussion on upper GI tumours: management of a patient with a middle-third locally advanced squamous-cell carcinoma

关于上消化道肿瘤的多学科讨论:中段局部晚期鳞状细胞癌患者的管理

Petrillo, A; Fleitas-Kanonnikoff, T; Nilsson, M; Leong, T; van Laarhoven, H W M

Controversies in upper GI oncology: definition and management of oligometastatic gastroesophageal adenocarcinoma

上消化道肿瘤学争议:寡转移性胃食管腺癌的定义和治疗

Petrillo, A; Piessen, G; van Laarhoven, H W M

Controversies in upper GI oncology: role of radiotherapy in non-metastatic gastroesophageal adenocarcinoma

上消化道肿瘤学争议:放射治疗在非转移性胃食管腺癌中的作用

Petrillo, A; Verheij, M; Leong, T

Multidisciplinary discussion in upper GI tumours: management of a patient with a locally advanced Siewert II gastroesophageal junctional adenocarcinoma

上消化道肿瘤的多学科讨论:局部晚期Siewert II期胃食管交界处腺癌患者的管理

Petrillo, A; Fleitas-Kanonnikoff, T; Nilsson, M; Leong, T; van Laarhoven, H W M

Controversies in upper GI oncology: MSI-H in gastroesophageal adenocarcinoma

上消化道肿瘤学争议:胃食管腺癌中的MSI-H

Petrillo, A; Derks, S; Smyth, E C

Controversies in upper GI oncology: early-onset gastric cancer

上消化道肿瘤学争议:早发性胃癌

Petrillo, A; Alsina, M; Ben-Aharon, I

EORTC stomach cancer PD-L1 biomarker European initiative: the ASPIRE study protocol

欧洲癌症研究与治疗组织(EORTC)胃癌PD-L1生物标志物欧洲倡议:ASPIRE研究方案

Petrillo, A; Oudijk, L; Sundar, R; Daumer, C; Casas, J; D'Haese, D; Mauer, M; van Grieken, N; Smyth, E C; Moehler, M

Regorafenib monotherapy as second-line treatment of patients with RAS-mutant advanced colorectal cancer (STREAM): an academic, multicenter, single-arm, two-stage, phase II study

瑞戈非尼单药治疗RAS突变型晚期结直肠癌患者二线治疗(STREAM):一项学术性、多中心、单臂、两阶段II期研究

Cardone, C; De Stefano, A; Rosati, G; Cassata, A; Silvestro, L; Borrelli, M; Di Gennaro, E; Romano, C; Nappi, A; Zanaletti, N; Foschini, F; Casaretti, R; Tatangelo, F; Lastoria, S; Raddi, M; Bilancia, D; Granata, V; Setola, S; Petrillo, A; Vitagliano, C; Gargiulo, P; Arenare, L; Febbraro, A; Martinelli, E; Ciardiello, F; Delrio, P; Budillon, A; Piccirillo, M C; Avallone, A

Controversies in upper GI oncology: first-line checkpoint inhibitor use in metastatic GEA: guided by PD-L1 CPS or not?

上消化道肿瘤学中的争议:转移性胃食管腺癌一线免疫检查点抑制剂的使用:是否以PD-L1 CPS为指导?

Petrillo, A; Maron, S B; Sundar, R